Wall Street steadied after Monday's freak out over AI-linked mega cap valuations, with Nvidia (NASDAQ: NVDA) recouping some ...

NVIDIA (NASDAQ: NVDA) shares bounced back strongly Tuesday following Monday’s DeepSeek-related sell-off, which whipped out a ...

Trump ordered the U.S. to withdraw from the Paris climate agreement, placing the world's top historic emitter of greenhouse ...

Investing.com -- Steven Cohen, CEO of Point72, has expressed his expectation that markets could reach their peak within the next few months if this hasn't occurred already, according to headlines from ...

A cornerstone of Trump's vision includes a phased rollout of universal tariffs on all U.S. imports. His recently confirmed ...

Shares of Tectonic plummeted 41% Tuesday following news that a similar drug developed by Eli Lilly (NYSE: LLY) for chronic ...

Shares of Alibaba (NYSE: NYSE:BABA) climbed 2.8% as the company's latest AI model, Qwen2.5-Max, garnered significant interest ...

Nvidia shares slumped about 17% or close to $593 billion in market value - a record one-day loss for any company - on Monday ...

The FDA's approval is based on the results of the FLOW phase 3b kidney outcomes trial. The trial revealed that Ozempic® 1 mg significantly lowered the relative risk of worsening kidney disease, kidney ...

Last week's stumble in the dollar wiped out a quarter of the gains seen from the end of the third quarter, leading many ...

Investing.com -- In a recent development, the CEO of OpenAI, Sam Altman, has hinted at an exciting upcoming phase of ...

Kedia, a seasoned financial services professional with nearly 30 years of experience, has been with U.S. Bancorp since 2016. Her previous roles include global executive positions at State Street (NYSE ...